Cary Street Partners Investment Advisory LLC Illumina, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$128.91 - $192.44 $89,592 - $133,745	-695 Reduced 48.26%	745 $102,000
Q2 2023 Aug 10, 2023	SELL	$183.43 - $232.67 $27,514 - $34,900	-150 Reduced 9.43%	1,440 $269,000
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $2,059 - $2,670	-11 Reduced 0.69%	1,590 $321,000
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $29,242 - $37,527	165 Added 11.49%	1,601 $305,000
Q2 2022 Aug 15, 2022	BUY	$181.58 - $368.0 $260,748 - $528,448	1,436 New	1,436 $265,000
Q4 2020 Feb 12, 2021	SELL	$292.7 - $370.96 $2,927 - $3,709	-10 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $2,685 - $4,007	10 New	10 $3,000

Others Institutions Holding ILMN

# of Institutions

901

Shares Held

137M

Call Options Held

1.22M

Put Options Held

1.43M

View Full List

About ILLUMINA, INC.

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

More about ILMN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account